Calbloc 5/10 5 mg/ 10mg Film coated tablets
PDF Leaflet Revision Date: 03 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension and angina pectoris.
Dosage (summary)
Initial dose 5 mg once daily, may increase to 10 mg after 10-14 days.
Special Populations
- Elderly
- Hepatic impairment
- Renal failure
Pregnancy & Breastfeeding
Safety in pregnancy/lactation not established; caution due to benzyl alcohol.
Key Drug Interactions
- CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin)
- Grapefruit juice
- Simvastatin
Contraindications
- Hypersensitivity to amlodipine or excipients
- Concomitant use with grapefruit juice
Common side effects
- Dizziness
- Headache
- Palpitations
- Nausea
Counselling Points
- Monitor for dizziness when driving or operating machinery.
- Report any allergic reactions or severe side effects.
Serious warnings
- Risk of hypotension with CYP3A4 inhibitors
- Potential for pulmonary edema in heart failure patients
Important Disclaimer
The Calbloc 5/10 5 mg/ 10mg Film coated tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
